Effect of Capsular Repair on the Outcomes of Direct Anterior Total Hip Arthroplasty.
Primary Purpose
Coxarthrosis
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Capsule repair
capsulectomy
Sponsored by
About this trial
This is an interventional treatment trial for Coxarthrosis
Eligibility Criteria
Inclusion Criteria:
- Elective unilateral or bilateral primary total hip arthroplasty
- Direct anterior surgical approach
- 18 years of age or older
- Avascular necrosis of the hip
Exclusion Criteria:
- Rheumatoid arthritis of the hip
- Revision hip arthroplasty
- Younger than 18 years of age
- Crowe type 3 and 4 coxarthrosis
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Group A
Group B
Arm Description
Direct anterior hip arthroplasty with capsule repair.
Surgery that the surgeon will not perform capsule repair after performing an initial capsulectomy during total hip arthroplasty
Outcomes
Primary Outcome Measures
Pelvis magnetic resonance ımages(MRI) evaluation of patients who underwent direct anterior total hip arthroplasty
The new capsule mass will be evaluated by an independent radiologist. adiologist will evaluate the volume of the new capsule structure in cubic millimeter
Secondary Outcome Measures
Full Information
NCT ID
NCT04570748
First Posted
July 23, 2020
Last Updated
September 25, 2020
Sponsor
Bezmialem Vakif University
1. Study Identification
Unique Protocol Identification Number
NCT04570748
Brief Title
Effect of Capsular Repair on the Outcomes of Direct Anterior Total Hip Arthroplasty.
Official Title
Effect of Capsular Repair on the Outcomes of Direct Anterior Total Hip Arthroplasty.
Study Type
Interventional
2. Study Status
Record Verification Date
September 2020
Overall Recruitment Status
Unknown status
Study Start Date
November 30, 2020 (Anticipated)
Primary Completion Date
July 30, 2021 (Anticipated)
Study Completion Date
July 30, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Bezmialem Vakif University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Total hip arthroplasty is a successful surgical procedure performed as a last-line treatment in primary and secondary coxarthrosis.
Recently, the direct anterior approach (DAA) has gained popularity by maintaining abduction force and reducing dislocation rates.
Soft tissue stability in the anterior is increased by adding capsule repair with the preservation of the posterior structures in the DAA.
The degradation of the biological structure of the capsule due to degenerative changes in the end stage coxarthrosis questions the effectiveness of the capsule repair. therefore, the effect of capsule repair on stability is still controversial.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coxarthrosis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
160 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Group A
Arm Type
Experimental
Arm Description
Direct anterior hip arthroplasty with capsule repair.
Arm Title
Group B
Arm Type
Active Comparator
Arm Description
Surgery that the surgeon will not perform capsule repair after performing an initial capsulectomy during total hip arthroplasty
Intervention Type
Procedure
Intervention Name(s)
Capsule repair
Intervention Description
Direct anterior hip arthroplasty with or without capsule repair
Intervention Type
Procedure
Intervention Name(s)
capsulectomy
Intervention Description
capsulectomy without repair
Primary Outcome Measure Information:
Title
Pelvis magnetic resonance ımages(MRI) evaluation of patients who underwent direct anterior total hip arthroplasty
Description
The new capsule mass will be evaluated by an independent radiologist. adiologist will evaluate the volume of the new capsule structure in cubic millimeter
Time Frame
one year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Elective unilateral or bilateral primary total hip arthroplasty
Direct anterior surgical approach
18 years of age or older
Avascular necrosis of the hip
Exclusion Criteria:
Rheumatoid arthritis of the hip
Revision hip arthroplasty
Younger than 18 years of age
Crowe type 3 and 4 coxarthrosis
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effect of Capsular Repair on the Outcomes of Direct Anterior Total Hip Arthroplasty.
We'll reach out to this number within 24 hrs